Ibrahim Azar Selected Research

Disease Progression

12/2023

Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ibrahim Azar Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023
1	Disease Progression 12/2023
1	Adenocarcinoma 12/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022
1	Microsatellite Instability 01/2022
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Carcinogenesis 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 12/2020
1	Pica (Geophagia) 12/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Proteinuria 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Thrombotic Microangiopathies 01/2017
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2017

Drug/Important Bio-Agent (IBA)

2	sotorasibIBA 12/2023 - 03/2023
2	adagrasibIBA 12/2023 - 03/2023
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2017
1	130-nm albumin-bound paclitaxelIBA 12/2023
1	selinexorIBA 12/2023
1	Gemcitabine FDA Link 12/2023
1	Exportin 1 ProteinIBA 12/2023
1	AlbuminsIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Protein Isoforms (Isoforms)IBA 03/2023
1	PlatinumIBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	Carboplatin (JM8)FDA LinkGeneric 10/2022
1	MT 17IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	human ERBB2 proteinIBA 01/2021
1	AntibodiesIBA 01/2021
1	trastuzumab deruxtecanIBA 01/2021
1	pertuzumabIBA 01/2021
1	Topoisomerase I InhibitorsIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	IronIBA 12/2020
1	Sunitinib (Sutent)FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017

Therapy/Procedure

5	Therapeutics 12/2023 - 12/2020
1	Oral Administration 03/2023
1	Drug Therapy (Chemotherapy) 10/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Cardiac Catheters 01/2022